- 专利标题: Port interface for drug delivery device
-
申请号: US17843133申请日: 2022-06-17
-
公开(公告)号: US12064594B2公开(公告)日: 2024-08-20
- 发明人: Christina Rabolli
- 申请人: Becton, Dickinson and Company
- 申请人地址: US NJ Franklin Lakes
- 专利权人: Becton, Dickinson and Company
- 当前专利权人: Becton, Dickinson and Company
- 当前专利权人地址: US NJ Franklin Lakes
- 代理机构: The Webb Law Firm
- 主分类号: A61M5/142
- IPC分类号: A61M5/142 ; A61M5/145 ; A61M5/158 ; A61M5/20 ; A61M5/24 ; A61M5/31 ; A61M5/315 ; A61M5/42 ; A61M39/02
摘要:
A drug delivery device includes a housing, a cartridge received within the housing, with the cartridge configured to receive a medicament, a drive assembly received within the housing and configured to engage the cartridge and dispense medicament from the cartridge, and a needle actuator assembly received within the housing, with the needle actuator assembly including a patient needle configured to pierce a patient's skin. A bottom surface of the housing defines a port interface configured to receive an implanted injection port.
公开/授权文献
- US20220323679A1 Port Interface for Drug Delivery Device 公开/授权日:2022-10-13
信息查询
IPC分类: